Systematic Review and Meta-Analysis of the Incidence of Chronic Kidney Disease After Pediatric Critical Illness

Author:

Akinkugbe Olugbenga123ORCID,Marchetto Luca4,Martin Isaac35,Chia Shin Hann6

Affiliation:

1. Department of Critical Care Medicine, The Hospital for Sick Children, Toronto, ON, Canada.

2. Interdepartmental Division of Critical Care Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

3. Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

4. Pediatric Intensive Care Unit, Department of Women’s and Children’s Health, University Hospital of Padua, Padua, Italy.

5. Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

6. Department of Cardiothoracic Anaesthesia, South Tees NHS Foundation Trust, The James Cook University Hospital, Middlesbrough, United Kingdom.

Abstract

OBJECTIVE: Survivors of pediatric critical illnesses are at risk of significant long-term organ sequelae. Chronic kidney disease (CKD) is a complication of critical illness (and ICU interventions) associated with growth impairment, cardiovascular disease, and early death. Our objective was to synthesize the evidence on the incidence of CKD among survivors of pediatric critical illness. DATA SOURCES: MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Register of Controlled Trials from inception to February 2024. STUDY SELECTION: Observational studies reporting the incidence of de novo CKD among survivors of pediatric critical illness. DATA EXTRACTION: Two reviewers independently extracted data on study design, setting, population, demographics, diagnostic criteria, and outcome. DATA SYNTHESIS: Meta-analysis was used to describe the incidence of CKD among survivors, risk of bias (RoB) assessed using the Joanna Briggs Institute Tool, and strength and reliability of evidence assessed with GRADE (Grading of Recommendations, Assessment, Development, and Evaluations). CKD was quantified as an estimated glomerular filtration rate (eGFR) less than 90 mL/min/1.73 m2 (outcome 1), eGFR less than 60 mL/min/1.73 m2 (outcome 2), and end-stage renal disease (ESRD) as eGFR less than 15 mL/min per 1.73 m2 (outcome 3). Twelve studies (3642 patients) met selection criteria and reported at least one measure of CKD. The median duration of follow-up was 2, 3.6, and 5 years, respectively, for outcomes 1, 2, and 3. For each threshold, the pooled estimate of CKD incidence was 24% (95% CI, 16–32%) for eGFR less than 90, 14% (95% CI, 6–23%) less than 60, and 4% (95% CI, 0–7%) for ESRD. The overall quality assessment indicated a moderate RoB. CONCLUSIONS: Among a heterogenous population of pediatric critical illness survivors, an important minority of survivors developed CKD or ESRD. This study highlights the importance of diagnostic criteria for reporting, a greater focus on postcritical care surveillance and follow-up to identify those with CKD. Further study would facilitate the delineation of high-risk groups and strategies for improved outcomes.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference38 articles.

1. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.;Levin;Kidney Int Suppl (2011),2013

2. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease.;Stevens;Kidney Int,2024

3. Long-term kidney outcomes following dialysis-treated childhood acute kidney injury: A population-based cohort study.;Robinson;J Am Soc Nephrol,2021

4. Chronic kidney disease in children.;Becherucci;Clin Kidney J,2016

5. Impact of chronic kidney disease on brain structure and function.;Steinbach;Front Neurol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3